ATA363479A - Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen - Google Patents

Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen

Info

Publication number
ATA363479A
ATA363479A AT0363479A AT363479A ATA363479A AT A363479 A ATA363479 A AT A363479A AT 0363479 A AT0363479 A AT 0363479A AT 363479 A AT363479 A AT 363479A AT A363479 A ATA363479 A AT A363479A
Authority
AT
Austria
Prior art keywords
prostacycline
stabilizing
compounds
pharmacologically active
formulations
Prior art date
Application number
AT0363479A
Other languages
English (en)
Other versions
AT365926B (de
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ATA363479A publication Critical patent/ATA363479A/de
Application granted granted Critical
Publication of AT365926B publication Critical patent/AT365926B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0363479A 1978-05-17 1979-05-16 Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen AT365926B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17

Publications (2)

Publication Number Publication Date
ATA363479A true ATA363479A (de) 1981-07-15
AT365926B AT365926B (de) 1982-02-25

Family

ID=10141640

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0363479A AT365926B (de) 1978-05-17 1979-05-16 Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen
AT79101516T ATE4411T1 (de) 1978-05-17 1979-05-17 Prostaglandin-verbindungen enthaltende pharmazeutische praeparate und verfahren zu deren herstellung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT79101516T ATE4411T1 (de) 1978-05-17 1979-05-17 Prostaglandin-verbindungen enthaltende pharmazeutische praeparate und verfahren zu deren herstellung.

Country Status (28)

Country Link
US (1) US4335139A (de)
EP (1) EP0005768B1 (de)
JP (1) JPS54163809A (de)
KR (1) KR830000527B1 (de)
AT (2) AT365926B (de)
AU (1) AU525695B2 (de)
BE (1) BE876296A (de)
CA (1) CA1141661A (de)
CH (1) CH641044A5 (de)
CS (1) CS214798B2 (de)
DE (2) DE2966046D1 (de)
DK (1) DK156004C (de)
ES (1) ES480597A1 (de)
FI (1) FI68359C (de)
FR (1) FR2425856A1 (de)
GR (1) GR68452B (de)
HU (1) HU182746B (de)
IL (1) IL57298A (de)
IT (1) IT1116840B (de)
LU (1) LU81272A1 (de)
MC (1) MC1265A1 (de)
NL (1) NL7903871A (de)
NZ (1) NZ190462A (de)
PH (1) PH15850A (de)
PL (1) PL134004B1 (de)
SE (1) SE450930B (de)
SU (1) SU978715A3 (de)
ZA (1) ZA787353B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
KR0158870B1 (ko) * 1988-06-17 1998-12-01 마틴 에이. 로쓰블랫 폐순환 승압의 치료, 예방 또는 진단용 조성물
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (de) * 2001-03-07 2002-09-11 Bruce Daniels Zusammensetzungen zur Behandlung und Verhütung von Gefässerkrankungen und Hypertonie
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
DE602006005423D1 (de) * 2005-06-29 2009-04-16 Verisfield Uk Ltd Pharmazeutische Zusammensetzungen von Risperidon in wässriger Lösung
US8318802B2 (en) 2006-02-03 2012-11-27 Actelion Pharmaceuticals Ltd. Epoprostenol formulation and method of making thereof
CN103181893A (zh) 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
JPS542335A (en) * 1977-05-20 1979-01-09 Wellcome Found Medical composition

Also Published As

Publication number Publication date
DK201879A (da) 1979-11-18
CA1141661A (en) 1983-02-22
FR2425856A1 (fr) 1979-12-14
CH641044A5 (de) 1984-02-15
ATE4411T1 (de) 1983-08-15
KR830000527B1 (ko) 1983-03-12
EP0005768B1 (de) 1983-08-10
AU525695B2 (en) 1982-11-25
DE2920020A1 (de) 1979-11-29
US4335139A (en) 1982-06-15
ZA787353B (en) 1980-08-27
SU978715A3 (ru) 1982-11-30
JPS54163809A (en) 1979-12-26
LU81272A1 (fr) 1979-12-07
CS214798B2 (en) 1982-05-28
PL215627A1 (de) 1981-08-07
FI68359C (fi) 1985-09-10
DE2920020C2 (de) 1988-09-01
BE876296A (fr) 1979-11-16
ES480597A1 (es) 1980-08-16
GR68452B (de) 1981-12-30
DE2966046D1 (en) 1983-09-15
SE7904284L (sv) 1979-11-18
JPS6358810B2 (de) 1988-11-17
HU182746B (en) 1984-03-28
NL7903871A (nl) 1979-11-20
IT7949064A0 (it) 1979-05-16
DK156004C (da) 1989-11-06
PL134004B1 (en) 1985-07-31
IL57298A0 (en) 1979-09-30
PH15850A (en) 1983-04-13
IL57298A (en) 1983-09-30
MC1265A1 (fr) 1980-03-28
FR2425856B1 (de) 1982-06-25
AT365926B (de) 1982-02-25
SE450930B (sv) 1987-08-17
AU4704279A (en) 1979-11-22
NZ190462A (en) 1982-05-31
FI791565A (fi) 1979-11-18
IT1116840B (it) 1986-02-10
FI68359B (fi) 1985-05-31
DK156004B (da) 1989-06-12
EP0005768A1 (de) 1979-12-12

Similar Documents

Publication Publication Date Title
SE8800731L (sv) Fenylkarbamat
NO160850C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(bicykliske heterocyklyl)-4-piperidinaminer.
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
SE8403487L (sv) Farmaceutisk komposition
DK163235C (da) Analogifremgangsmaade til fremstilling af farmaceutisk aktive 3-hydroxysmoersyresalte
DK529888A (da) Substituerede n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamider
AT365926B (de) Verfahren zum stabilisieren von pharmakologisch aktiven prostacyclinverbindungen
NL7612771A (nl) Biologisch actieve verbindingen en werkwijze voor de bereiding daarvan.
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
NO812556L (no) Fremgangsmaate for stabilisering av tienopyridinderivater
NO883261D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
IT7924028A0 (it) Uso di acidi arilamino benzoici come agenti ipoglicemizzanti e composizioni farmaceutiche per detto uso.
IT8620208A0 (it) Eteri del 7-ossabicicloeptano sostituiti quali analoghi di prostaglandine e relative composizioni farmaceutiche.
DK161833C (da) Analogifremgangsmaade til fremstilling af n-(vinblastinoyl-23)-derivater af aminosyrer eller farmaceutisk acceptable syreadditionssalte deraf
IT1055787B (it) Procedimento di preparazione dell amino 4 fenil 2 amino 5 benzimidazolo
SE7807225L (sv) Sett att framstella 4-hydroxicinnolin-derivat
ATA439276A (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praparaten
GB2021581A (en) Stabilisation of PGl2 derivatives
ES535408A0 (es) Un metodo de producir una composicion farmaceutica que contiene isoxicamato de l-arginina como ingrediente activo.
JPS51136602A (en) Process for preparation of amino acid or peptide

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELA Expired due to lapse of time